Arthritis, Musculoskeletal and Skin Diseases Research in Washington
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $79.0 million to recipients in Washington in 60 grants from fiscal 2021 to 2025, 3.0% of the program's national total. University of Washington received the most, $48.7 million.
- Awarded in Washington$79.0 million
- Awards60
- Share of the program3.0%
- Rank among states13th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 33 | $15.6 million |
| FY 2022 | 34 | $16.2 million |
| FY 2023 | 35 | $15.2 million |
| FY 2024 | 32 | $15.1 million |
| FY 2025 | 33 | $16.8 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Washington | Colleges and universities | 33 | $48.7 million |
| Seattle Children's Hospital | Nonprofits | 6 | $9.2 million |
| Fred Hutchinson Cancer Center | Nonprofits | 4 | $6.7 million |
| Washington State University | Colleges and universities | 8 | $6.0 million |
| Sage Bionetworks | Nonprofits | 1 | $2.4 million |
| Kinea Bio Inc | Small businesses | 2 | $1.8 million |
| Benaroya Research Institute at Virginia Mason | Nonprofits | 1 | $1.7 million |
| Seattle Institute for Biomedical and Clinical Research | Nonprofits | 2 | $1.6 million |
| Cyrus Biotechnology, Inc | Small businesses | 1 | $298,915 |
| Gsno Therapeutics, Inc. | Small businesses | 1 | $279,654 |
Open opportunities under this program
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 62 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Washington?
$79.0 million from fiscal 2021 to 2025, across 60 awards. Washington ranks 13th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Washington?
The largest recipient is University of Washington, with $48.7 million in 33 awards. Next are Seattle Children's Hospital and Fred Hutchinson Cancer Center.
Can organizations in Washington apply now?
Yes, 62 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Allergy and Infectious Diseases Research
- Child Care and Development Block Grant